BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 22212180)

  • 1. Does a 'code stroke' rapid access protocol decrease door-to-needle time for thrombolysis?
    Tai YJ; Weir L; Hand P; Davis S; Yan B
    Intern Med J; 2012 Dec; 42(12):1316-24. PubMed ID: 22212180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombolysis for acute ischemic stroke: do patients treated out of hours have a worse outcome?
    Fang K; Churilov L; Weir L; Dong Q; Davis S; Yan B
    J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):427-32. PubMed ID: 23635920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergency medical service hospital prenotification is associated with improved evaluation and treatment of acute ischemic stroke.
    Lin CB; Peterson ED; Smith EE; Saver JL; Liang L; Xian Y; Olson DM; Shah BR; Hernandez AF; Schwamm LH; Fonarow GC
    Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):514-22. PubMed ID: 22787065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stroke code improves intravenous thrombolysis administration in acute ischemic stroke.
    Chen CH; Tang SC; Tsai LK; Hsieh MJ; Yeh SJ; Huang KY; Jeng JS
    PLoS One; 2014; 9(8):e104862. PubMed ID: 25111200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Impact of Implementation of a Stroke Protocol on Door-to-Needle Time in the Administration of Intravenous Tissue Plasminogen Activator.
    Hillen ME; He W; Al-Qudah Z; Wang W; Hidalgo A; Walia J
    J Stroke Cerebrovasc Dis; 2017 Jul; 26(7):1569-1572. PubMed ID: 28411038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality assurance monitoring of a citywide transportation protocol improves clinical indicators of intravenous tissue plasminogen activator therapy: a community-based, longitudinal study.
    Atsumi C; Hasegawa Y; Tsumura K; Ueda T; Suzuki K; Sugiyama M; Nozaki H; Suzuki S; Nakane M; Nagashima G; Kitamura T; Nikaido H; Sasanuma J
    J Stroke Cerebrovasc Dis; 2015 Jan; 24(1):183-8. PubMed ID: 25440326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset.
    Mathews MS; Sharma J; Snyder KV; Natarajan SK; Siddiqui AH; Hopkins LN; Levy EI
    Neurosurgery; 2009 Nov; 65(5):860-5; discussion 865. PubMed ID: 19834397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CODE FAST: a quality improvement initiative to reduce door-to-needle times.
    Busby L; Owada K; Dhungana S; Zimmermann S; Coppola V; Ruban R; Horn C; Rochestie D; Khaldi A; Hormes JT; Gupta R
    J Neurointerv Surg; 2016 Jul; 8(7):661-4. PubMed ID: 26089402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers to the use of intravenous tissue plasminogen activator for in-hospital strokes.
    Bunch ME; Nunziato EC; Labovitz DL
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):808-11. PubMed ID: 21640608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement in Door-to-Needle Time in Patients with Acute Ischemic Stroke via a Simple Stroke Activation Protocol.
    Tan BYQ; Ngiam NJH; Sunny S; Kong WY; Tam H; Sim TB; Leong BSH; Bhartendu C; Paliwal PR; Seet RCS; Chan BPL; Teoh HL; Sharma VK; Yeo LLL
    J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):1539-1545. PubMed ID: 29422380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocol adherence and safety of intravenous thrombolysis after telephone consultation with a stroke center.
    Uchino K; Massaro L; Jovin TG; Hammer MD; Wechsler LR
    J Stroke Cerebrovasc Dis; 2010; 19(6):417-23. PubMed ID: 21051004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of a code stroke protocol on the door-to-needle time for IV thrombolysis: a feasibility study.
    Vanhoucke J; Hemelsoet D; Achten E; De Herdt V; Acou M; Vereecke E; Hachimi-Idrissi S
    Acta Clin Belg; 2020 Aug; 75(4):267-274. PubMed ID: 31081471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stroke mimics treated with thrombolysis: further evidence on safety and distinctive clinical features.
    Guillan M; Alonso-Canovas A; Gonzalez-Valcarcel J; Garcia Barragan N; Garcia Caldentey J; Hernandez-Medrano I; Defelipe-Mimbrera A; Sanchez-Gonzalez V; Terecoasa E; Alonso de Leciñana M; Masjuan J
    Cerebrovasc Dis; 2012; 34(2):115-20. PubMed ID: 22854315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative.
    Fonarow GC; Zhao X; Smith EE; Saver JL; Reeves MJ; Bhatt DL; Xian Y; Hernandez AF; Peterson ED; Schwamm LH
    JAMA; 2014 Apr 23-30; 311(16):1632-40. PubMed ID: 24756513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of intravenous thrombolysis for acute ischemic stroke in Asia.
    Sharma VK; Ng KW; Venketasubramanian N; Saqqur M; Teoh HL; Kaul S; Srivastava PM; Sergentanis T; Suwanwela N; Nguyen TH; Lawrence Wong KS; Chan BP
    Int J Stroke; 2011 Dec; 6(6):523-30. PubMed ID: 22111797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of thrombolytic therapy after stroke-bypass transportation: the Maria Prehospital Stroke Scale score.
    Hasegawa Y; Sasaki N; Yamada K; Ono H; Kumai J; Tsumura K; Suzuki K; Nozaki H; Nakayama H; Takumi I; Nikaido H; Katabami T; Ueda T; Suzuki S; Iwai R; Takahashi H; Shigeno T
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):514-9. PubMed ID: 23489953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drill down analysis of door-to-needle time of acute ischemic stroke patients treated with intravenous tissue plasminogen activator.
    Schrock JW; Lum M
    Am J Emerg Med; 2014 Nov; 32(11):1330-3. PubMed ID: 25195044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospital prenotification of stroke patients by emergency medical services improves stroke time targets.
    McKinney JS; Mylavarapu K; Lane J; Roberts V; Ohman-Strickland P; Merlin MA
    J Stroke Cerebrovasc Dis; 2013 Feb; 22(2):113-8. PubMed ID: 21820919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimising time to treatment: targeted strategies to minimise time to thrombolysis for acute ischaemic stroke.
    Tai YJ; Yan B
    Intern Med J; 2013 Nov; 43(11):1176-82. PubMed ID: 23734983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 24/7 Neurocritical Care Nurse Practitioner Coverage Reduced Door-to-Needle Time in Stroke Patients Treated with Tissue Plasminogen Activator.
    Moran JL; Nakagawa K; Asai SM; Koenig MA
    J Stroke Cerebrovasc Dis; 2016 May; 25(5):1148-1152. PubMed ID: 26907680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.